IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,400 | +10.6% | 2,500 | 0.0% | 0.00% | – |
| Q2 2023 | $102,575 | -4.3% | 2,500 | -16.7% | 0.00% | – |
| Q1 2023 | $107,220 | +13.6% | 3,000 | +20.0% | 0.00% | – |
| Q4 2022 | $94,425 | -14.9% | 2,500 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $111,000 | +19.4% | 2,500 | 0.0% | 0.00% | – |
| Q2 2022 | $93,000 | -7.9% | 2,500 | -7.9% | 0.00% | – |
| Q1 2022 | $101,000 | +26.2% | 2,714 | +3.4% | 0.00% | – |
| Q4 2021 | $80,000 | -9.1% | 2,626 | 0.0% | 0.00% | – |
| Q3 2021 | $88,000 | -13.7% | 2,626 | +2.8% | 0.00% | – |
| Q2 2021 | $102,000 | -76.3% | 2,554 | -73.3% | 0.00% | -100.0% |
| Q1 2021 | $430,000 | -21.2% | 9,558 | -1.0% | 0.00% | -33.3% |
| Q4 2020 | $546,000 | +4.0% | 9,658 | -12.7% | 0.00% | 0.0% |
| Q3 2020 | $525,000 | -20.5% | 11,062 | -1.1% | 0.00% | -25.0% |
| Q2 2020 | $660,000 | +24.8% | 11,188 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $529,000 | -15.6% | 11,188 | +7.8% | 0.00% | +33.3% |
| Q4 2019 | $627,000 | +43.8% | 10,382 | +42.6% | 0.00% | 0.0% |
| Q3 2019 | $436,000 | -8.8% | 7,282 | -2.0% | 0.00% | 0.0% |
| Q2 2019 | $478,000 | -15.8% | 7,434 | +6.3% | 0.00% | -25.0% |
| Q1 2019 | $568,000 | +48.7% | 6,994 | -1.1% | 0.00% | +33.3% |
| Q4 2018 | $382,000 | +4.1% | 7,071 | -0.7% | 0.00% | +50.0% |
| Q3 2018 | $367,000 | +15.4% | 7,118 | -6.9% | 0.00% | 0.0% |
| Q2 2018 | $318,000 | +1.9% | 7,642 | +8.1% | 0.00% | 0.0% |
| Q1 2018 | $312,000 | +3020.0% | 7,071 | +3641.3% | 0.00% | – |
| Q4 2017 | $10,000 | 0.0% | 189 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | 0.0% | 189 | 0.0% | 0.00% | – |
| Q2 2017 | $10,000 | +25.0% | 189 | 0.0% | 0.00% | – |
| Q1 2017 | $8,000 | -11.1% | 189 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | +28.6% | 189 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | +133.3% | 189 | +40.0% | 0.00% | – |
| Q2 2016 | $3,000 | -40.0% | 135 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | -58.3% | 135 | -30.8% | 0.00% | – |
| Q4 2015 | $12,000 | – | 195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |